BQ Blue’s Special Research section reviews high-quality, detailed equity and economic research reports from top Indian brokers, asset managers and research institutions as a whole. These reports provide Bloomberg Quint subscribers with the opportunity to gain a better understanding of the enterprise, sector, and economy.
Colgate-Palmolive India Ltd.’s second quarter 2010 results were in line with our expectations.
Average sales growth for the second quarter of 2010 was 5.2%, in the range of 4-6% seen in recent quarters, with little sign of improvement despite consistent advertising spending. ..
The launch of a non-oral care portfolio and investment in the “Twice a Day Brush” campaign appear to be postponed, allowing a quick return to the double-digit sales growth seen in 2008-15. The sex is low.
We maintain a neutral view that the top line is sluggish, material cost pressure is rising, and there is limited room for price increases.
There is no evidence that Colgate is regaining the lost market share in its core oral care business.
Click on the attachment to read the entire report.
This report has been produced by an outside party. BloombergQuint does not guarantee the accuracy of its contents and does not take any responsibility in any way. The content of this section does not constitute investment advice. To do this, you should always consult an expert based on your individual needs. The views contained in the report are those of the author entity and do not represent the views of Bloomberg Quint.
The user is not licensed to copy, modify or distribute the content without the permission of the original owner.
Colgate India Second Quarter Review-Sales Growth Still Slow. Poor outlook: Motilal Oswal
https://www.bloombergquint.com/research-reports/colgate-india-q2-review-sales-growth-remains-tepid-outlook-weak-motilal-oswal Colgate India Second Quarter Review-Sales Growth Still Slow. Poor outlook: Motilal Oswal